CXCL9 and CXCL10 predict survival and are regulated by cyclooxygenase inhibition in advanced serous ovarian cancer
出版年份 2016 全文链接
标题
CXCL9 and CXCL10 predict survival and are regulated by cyclooxygenase inhibition in advanced serous ovarian cancer
作者
关键词
-
出版物
BRITISH JOURNAL OF CANCER
Volume 115, Issue 5, Pages 553-563
出版商
Springer Nature
发表日期
2016-08-05
DOI
10.1038/bjc.2016.172
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Tumor Infiltrating Lymphocytes in Ovarian Cancer
- (2015) Maria Luisa Gasparri et al. Asian Pacific Journal of Cancer Prevention
- IP-10/CXCL10 induction in human pancreatic cancer stroma influences lymphocytes recruitment and correlates with poor survival
- (2015) Serena Lunardi et al. Oncotarget
- High STAT1 mRNA levels but not its tyrosine phosphorylation are associated with macrophage infiltration and bad prognosis in breast cancer
- (2014) Piotr Tymoszuk et al. BMC CANCER
- Prognostic Impact of Human Leukocyte Antigen Class I Expression and Association of Platinum Resistance with Immunologic Profiles in Epithelial Ovarian Cancer
- (2014) T. Mariya et al. Cancer Immunology Research
- Past, Present and Future Strategies of Immunotherapy in Gynecological Malignancies
- (2013) F. Bellati et al. CURRENT MOLECULAR MEDICINE
- Monoclonal antibodies therapies for ovarian cancer
- (2013) Umberto Leone Roberti Maggiore et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- Evidence for the antagonistic form of CXC-motif chemokine CXCL10 in serous epithelial ovarian tumours
- (2013) Adam Rainczuk et al. INTERNATIONAL JOURNAL OF CANCER
- Serum CXCL9 Levels Are Associated with Tumor Progression and Treatment Outcome in Patients with Nasopharyngeal Carcinoma
- (2013) Li-Jen Hsin et al. PLoS One
- A randomized phase II study investigating the addition of the specific COX-2 inhibitor celecoxib to docetaxel plus carboplatin as first-line chemotherapy for stage IC to IV epithelial ovarian cancer, Fallopian tube or primary peritoneal carcinomas: the DoCaCel study
- (2012) A. K. L. Reyners et al. ANNALS OF ONCOLOGY
- The Next Challenge in Cancer Immunotherapy: Controlling T-Cell Traffic to the Tumor
- (2012) J.-P. Abastado CANCER RESEARCH
- CXCR3+ T Regulatory Cells Selectively Accumulate in Human Ovarian Carcinomas to Limit Type I Immunity
- (2012) N. Redjimi et al. CANCER RESEARCH
- NF- B Hyperactivation in Tumor Tissues Allows Tumor-Selective Reprogramming of the Chemokine Microenvironment to Enhance the Recruitment of Cytolytic T Effector Cells
- (2012) R. Muthuswamy et al. CANCER RESEARCH
- Combination strategies to enhance antitumor ADCC
- (2012) Holbrook E Kohrt et al. Immunotherapy
- Interaction between treg cells and angiogenesis: A dark double track
- (2012) Maria Luisa Gasparri et al. INTERNATIONAL JOURNAL OF CANCER
- Monoclonal antibodies for the treatment of cancer
- (2012) Casey W. Shuptrine et al. SEMINARS IN CANCER BIOLOGY
- Current knowledge and open issues regarding Bevacizumab in gynaecological neoplasms
- (2011) Filippo Bellati et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- TNF and IFN Synergistically Enhance Transcriptional Activation of CXCL10 in Human Airway Smooth Muscle Cells via STAT-1, NF- B, and the Transcriptional Coactivator CREB-binding Protein
- (2010) D. L. Clarke et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Immunotherapy for Ovarian Cancer: What's Next?
- (2010) Lana E. Kandalaft et al. JOURNAL OF CLINICAL ONCOLOGY
- Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments
- (2009) I. Kryczek et al. BLOOD
- Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer
- (2009) Carsten Denkert et al. JOURNAL OF CLINICAL ONCOLOGY
- Expression profiling identifies genes that predict recurrence of breast cancer after adjuvant CMF-based chemotherapy
- (2008) Katja Specht et al. BREAST CANCER RESEARCH AND TREATMENT
- Natural Killer Cell Accumulation in Tumors Is Dependent on IFN- and CXCR3 Ligands
- (2008) M. Wendel et al. CANCER RESEARCH
- Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome
- (2008) R. W. Tothill et al. CLINICAL CANCER RESEARCH
- Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type and BRCA1 loss
- (2008) Blaise Clarke et al. MODERN PATHOLOGY
- Classification using hierarchical clustering of tumor-infiltrating immune cells identifies poor prognostic ovarian cancers with high levels of COX expression
- (2008) Min Liu et al. MODERN PATHOLOGY
- Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma
- (2007) Markéta Tomšová et al. GYNECOLOGIC ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started